Merck KGaA (MKGAF) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - Specialty & Generic industry. The company is headquartered in Darmstadt, Germany. The current CEO is Belen Garijo Lopez.
MKGAF has IPO date of 2012-08-03, 59,020 full-time employees, listed on the Other OTC, a market capitalization of $58.16B.
Merck KGaA is a German science and technology company founded in 1668 and headquartered in Darmstadt. Operating through three primary segments—Life Science, Healthcare, and Electronics—the company serves diverse markets globally. Its Life Science division supplies tools, chemicals, equipment, and process technologies to academic institutions, biotech firms, and pharmaceutical manufacturers, while also offering testing and analytical solutions for environmental and nutritional applications. The Healthcare segment discovers and commercializes prescription drugs and biopharmaceuticals targeting oncology, neurology, immunology, fertility, endocrinology, cardiovascular disease, diabetes, and multiple sclerosis, alongside injection devices and monitoring software. The Electronics segment provides advanced materials and surface solutions for semiconductor, display, cosmetics, and industrial applications. Merck KGaA has established multiple licensing agreements to expand its oncology and specialty pharmaceutical pipeline and operates as a subsidiary of E. Merck KG.
